Therapeutic uses and methods
Abstract:
The specification discloses a method of treating muscular disorders such as muscular dystrophy comprising periodically administering an inhibitory oligonucleotide to human CD49d ((the alpha 4 chain of VLA-4).
Public/Granted literature
Information query
Patent Agency Ranking
0/0